Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis.

Jun Yong Frederick FrostDilip NazarethMartin Walshaw

Published in: F1000Research (2018)

Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime in the management of an acute pseudomonal pulmonary exacerbation.

Keyphrases

drug induced
liver injury
case report
gram negative
iron deficiency
multidrug resistant
chronic obstructive pulmonary disease
pulmonary hypertension
adverse drug
respiratory failure
liver failure
hepatitis b virus
acute respiratory distress syndrome